Augmedix Performance
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
The firm shows a Beta (market volatility) of -2.7, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Augmedix are expected to decrease by larger amounts. On the other hand, during market turmoil, Augmedix is expected to outperform it. Augmedix right now shows a risk of 0.0%. Please confirm Augmedix sortino ratio, as well as the relationship between the semi variance and day typical price , to decide if Augmedix will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Augmedix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Augmedix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 21.4 M |
Augmedix |
Augmedix Relative Risk vs. Return Landscape
If you would invest 235.00 in Augmedix on October 1, 2024 and sell it today you would earn a total of 0.00 from holding Augmedix or generate 0.0% return on investment over 90 days. Augmedix is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Augmedix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Augmedix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Augmedix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Augmedix, and traders can use it to determine the average amount a Augmedix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AUGX |
Based on monthly moving average Augmedix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Augmedix by adding Augmedix to a well-diversified portfolio.
Augmedix Fundamentals Growth
Augmedix Stock prices reflect investors' perceptions of the future prospects and financial health of Augmedix, and Augmedix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Augmedix Stock performance.
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 113.21 M | |||
| Shares Outstanding | 49.43 M | |||
| Price To Book | 11.09 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 44.85 M | |||
| EBITDA | (17.68 M) | |||
| Cash And Equivalents | 29.99 M | |||
| Cash Per Share | 0.80 X | |||
| Total Debt | 25.85 M | |||
| Debt To Equity | 1.54 % | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (15.44 M) | |||
| Earnings Per Share | (0.47) X | |||
| Total Asset | 66.71 M | |||
| Retained Earnings | (144.96 M) | |||
About Augmedix Performance
Evaluating Augmedix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Augmedix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Augmedix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.Things to note about Augmedix performance evaluation
Checking the ongoing alerts about Augmedix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Augmedix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Augmedix is not yet fully synchronised with the market data | |
| Augmedix generated a negative expected return over the last 90 days | |
| Augmedix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 44.85 M. Net Loss for the year was (19.17 M) with profit before overhead, payroll, taxes, and interest of 13.95 M. | |
| Augmedix currently holds about 29.99 M in cash with (15.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8. | |
| Over 85.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Augmedix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Augmedix's stock is overvalued or undervalued compared to its peers.
- Examining Augmedix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Augmedix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Augmedix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Augmedix's stock. These opinions can provide insight into Augmedix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |